A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP
Public ClinicalTrials.gov record NCT06362759. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Quarterly and Monthly TOUR006 in Participants With Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the safety, tolerability, pharmacokinetics, and CRP-lowering effect of quarterly and monthly subcutaneous administration of TOUR006 (also known as pacibekitug) in participants with chronic kidney disease and elevated hs-CRP.
Study identification
- NCT ID
- NCT06362759
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 143 participants
Conditions and interventions
Conditions
Interventions
- TOUR006 - 50 MG Drug
- TOUR006 - 25 MG Drug
- TOUR006 - 15 MG Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 15, 2024 (Actual)
- Primary completion
- Mar 6, 2025 (Actual)
- Completion
- Dec 4, 2025 (Actual)
- Last update posted
- Aug 11, 2026
2024 – 2025
United States locations
- U.S. sites
- 38
- U.S. states
- 22
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site - 0101 | Birmingham | Alabama | 35209 | — |
| Site - 0135 | Huntsville | Alabama | 35763 | — |
| Site - 0145 | Huntsville | Alabama | 35805 | — |
| Site - 0104 | Phoenix | Arizona | 85018 | — |
| Site - 0125 | San Dimas | California | 91773 | — |
| Site - 0112 | Valencia | California | 91355 | — |
| Site - 0128 | Valencia | California | 91355 | — |
| Site - 0136 | Stamford | Connecticut | 06905 | — |
| Site - 0113 | Greenacres City | Florida | 334667 | — |
| Site - 0149 | Pembroke Pines | Florida | 33024 | — |
| Site - 0144 | Plantation | Florida | 33317 | — |
| Site - 0119 | Port Orange | Florida | 32127 | — |
| Site - 0151 | Tampa | Florida | 33634 | — |
| Site - 0122 | Savannah | Georgia | 31406 | — |
| Site - 0106 | Chicago | Illinois | 60655 | — |
| Site - 0115 | Morton | Illinois | 61550 | — |
| Site - 0114 | Council Bluffs | Iowa | 51501 | — |
| Site - 0129 | Metairie | Louisiana | 70006 | — |
| Site - 0123 | Las Vegas | Nevada | 89121 | — |
| Site - 0130 | Middletown | New York | 10940 | — |
| Site - 0110 | Charlotte | North Carolina | 28208 | — |
| Site - 0117 | Fargo | North Dakota | 58104 | — |
| Site - 0120 | Cincinnati | Ohio | 45219 | — |
| Site - 0127 | Marion | Ohio | 43302 | — |
| Site - 0132 | Bethlehem | Pennsylvania | 18017 | — |
| Site - 0126 | Providence | Rhode Island | 02818 | — |
| Site - 0102 | Fort Mill | South Carolina | 29707 | — |
| Site - 0103 | Greenville | South Carolina | 29607 | — |
| Site - 0108 | Knoxville | Tennessee | 37923 | — |
| Site - 0148 | Greenville | Texas | 75402 | — |
| Site - 0105 | Houston | Texas | 77043 | — |
| Site - 0111 | Lampasas | Texas | 76550 | — |
| Site - 0150 | McKinney | Texas | 75069 | — |
| Site - 0107 | San Antonio | Texas | 78212 | — |
| Site - 0141 | San Antonio | Texas | 78255 | — |
| Site - 0109 | Manassas | Virginia | 20110 | — |
| Site - 0147 | Morgantown | West Virginia | 26505 | — |
| Site - 0134 | Kenosha | Wisconsin | 53144 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06362759, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 11, 2026 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06362759 live on ClinicalTrials.gov.